Magda Szubanski opens up on ‘incurable’ cancer, childhood darkness on 60 Minutes
Iconic Aussie actress Magda Szubanski has declared she has “nothing left to hide” – opening up on her…
Scientists reveals how cancer-causing p53 mutations remain invisible to the immune system
One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but…
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
Menta “Steve” Wallace shows a bottle of daraxonrasib, Revolution Medicines’ pancreatic cancer drug, at his home in The…
Johnny Young, Young Talent Time creator, dies aged 79
Tributes have flowed for beloved Aussie entertainer and Young Talent Time host Johnny Young, after his cancer death…
Young Talent Time host Johnny Young dies, aged 79
Young Talent Time host Johnny Young has died aged 79 following a brief battle with pancreatic cancer. “Johnny…
Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Red meat intake emerges as a potential pancreatic cancer risk factor
A review of nearly 2 million participants links higher red meat intake to pancreatic cancer risk, while the…
Experimental drug shows promise against NRAS-driven melanoma
A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a groundbreaking pathway-targeted therapy could be an effective…
Stealth nanoparticles improve pancreatic cancer treatment with fewer side effects
Pancreatic cancer is considered one of the most lethal cancer because it is often diagnosed late and is…
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
New study identifies potential compound for pancreatic cancer treatment
Announcing a new article publication in BIO Integration. Fat mass and obesity-associated protein (FTO), an epitranscriptomic regulator, has…
Why Revolution Medicines (RVMD) Is Up 6.2% After Early Zoldonrasib Pancreatic Cancer Data And What’s Next
In late June and early July 2026, Revolution Medicines reported Phase 1/2 data showing that its RAS G12D…